Skip to content
Equity Capital Market
  • Start Here
  • Research
    • LightPath Deal
    • Plug Power ATM
    • Standard Nuclear IPO
  • Latest
  • Stock Market
  • Market Education
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

smoke-free products

FDA Clears 20 Zyn Variants for Reduced-Risk Claims

September 12, 2026June 30, 2026 by Bruno
FDA Clears 20 Zyn Variants for Reduced-Risk Claims

FDA issued modified risk tobacco product orders for 20 Zyn nicotine pouch variants, the first MRTP authorization for the category and Philip Morris’s biggest smoke-free regulatory win since IQOS in 2020.

Categories Stock Market Tags fda mrtp, philip morris, smoke-free products, stock market, tobacco stocks, zyn

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Tax-Equivalent Yield: How to Compare Munis and Treasuries
  • Priority Technology Inks $1.6B Buyout With CEO and Searchlight
  • NCMI Buys Captivate for $275M to Form 48,000-Screen Ad Network
  • Zero-Coupon Bonds: How STRIPS Work, Pricing Math, and Taxes
  • AMC Launches $3.97B Financing Plan and Debt Tender Offer

About · Editorial Policy · Corrections · Disclaimer · Privacy · Contact

© 2026 Equity Capital Market • Built with GeneratePress